Follow the people · Insider

MA

Moshe Arkin

Insider · Director and 10% owner · ODYS

Moshe Arkin files insider transactions with the SEC as a director and 10% owner of Odysight.ai (ODYS). We hold 1 disclosed purchase or sale filed since 18 August 2006, 1 of them in the last 90 days.

  • Files forODYS
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure24 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 25 March 202620 August 2026Director and 10% owner · Odysight.ai (ODYS)7 Form 4 lines · source: SEC Form 4
  • Filed 4 May 20214 May 202110% owner · Werewolf Therapeutics (HOWL)5 Form 4 lines · source: SEC Form 4
  • Filed 16 August 200631 August 2011Vice Chairman · Perrigo Co (PRGO)1,071 Form 4 lines · source: SEC Form 4
  • Filed 9 September 201027 June 2011TenPercentOwnerOther · NeurogesX (NGSX)3 Form 4 lines · source: SEC Form 4
  • Filed 12 July 201015 July 2010Other role · Orexigen Therapeutics (OREX)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.